This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Inovio Pharmaceuticals Inc (INO)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 33.72M 5.65M 17.35M 20.00M
Receivables 3.30M 866.67K 506.32K 105.04K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 58.68M 15.97M 31.91M 22.88M
Property, Plant & Equipment, Gross 4.80M 2.48M 2.24M 2.08M
Accumulated Depreciation & Depletion 1.92M 2.12M 1.94M 1.80M
Property, Plant & Equipment, Net 2.89M 363.02K 295.78K 276.80K
Intangibles 5.72M 7.49M 9.31M 11.18M
Other Non-Current Assets 10.88M 11.21M 9.48M 11.62M
Total Non-Current Assets 29.60M 29.17M 29.20M 33.19M
Liabilities & Shareholder Equity
Total Assets 88.29M 45.14M 61.11M 56.07M
Accounts Payable 5.97M 1.04M 1.16M 5.09M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 19.54M 2.86M 5.18M 370.93K
Total Current Liabilities 28.97M 8.38M 11.04M 6.44M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 195.78K 164.39K 78.86K 53.19K
Other Non-Current Liabilities 6.22M 1.74M 2.12M 2.48M
Minority Interest -55.08K -44.02K -51.15K -24.95K
Total Non-Current Liabilities 6.87M 2.41M 2.75M 3.13M
Total Liabilities 35.83M 10.78M 13.79M 9.56M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 52.46M 34.35M 47.31M 46.50M
Common Par 210.30K 144.31K 134.97K 105.04K
Additional Paid In Capital 348.11M 263.90M 257.24M 241.23M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -295.79M -229.76M -210.09M -194.84M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -76.36K 73.36K 35.39K 2.85K
Total Capitalization 52.46M 34.35M 47.31M 46.50M
Total Equity 52.46M 34.35M 47.31M 46.50M
Total Liabilities & Stock Equity 88.29M 45.14M 61.11M 56.07M
Total Common Shares Outstanding 52.58M 36.08M 33.74M 26.26M
Preferred Shares 26.00 26.00 26.00 26.00
Treasury Shares 0.00 266.00 0.00 0.00
Basic Weighted Shares Outstanding 46.09M 34.13M 31.56M 25.80M
Diluted Weighted Shares Outstanding 46.09M 34.13M 31.56M 25.80M
Number of Employees 71 53 53 44
Number of Part-Time Employees 0 0 0 0
INO News

INO Inovio Pharmaceuticals Inc

Analysts Ratings for INO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET INO ANALYST REPORT

Brokerage Partners

INO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs